DH
DH
Definitive Healthcare Corp.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $61.53M ▲ | $73.54M ▲ | $-9.31M ▲ | -15.14% ▲ | $-0.09 ▲ | $-6.6M ▼ |
| Q3-2025 | $60.05M ▼ | $59.66M ▲ | $-14.84M ▼ | -24.71% ▼ | $-0.14 ▼ | $-209K ▼ |
| Q2-2025 | $60.75M ▲ | $50.78M ▼ | $-7.55M ▲ | -12.43% ▲ | $-0.07 ▲ | $8.52M ▲ |
| Q1-2025 | $59.19M ▼ | $228.55M ▲ | $-107.23M ▼ | -181.16% ▼ | $-0.95 ▼ | $-149.73M ▼ |
| Q4-2024 | $62.29M | $147.16M | $-59.08M | -94.84% | $-0.51 | $-73.97M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $180.89M ▼ | $735.49M ▼ | $356.5M ▼ | $378.99M ▲ |
| Q3-2025 | $185.92M ▲ | $755.53M ▼ | $365.86M ▲ | $284.85M ▼ |
| Q2-2025 | $184.2M ▼ | $770.14M ▼ | $358.91M ▼ | $303.62M ▼ |
| Q1-2025 | $200.67M ▼ | $808.66M ▼ | $372.75M ▼ | $322.78M ▼ |
| Q4-2024 | $290.16M | $1.09B | $482.19M | $444.38M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-17.15M ▲ | $2.72M ▼ | $56.35M ▲ | $-3.91M ▲ | $55.31M ▲ | $-1.72M ▼ |
| Q3-2025 | $-17.79M ▼ | $15.69M ▲ | $24.14M ▲ | $-12.47M ▲ | $27.33M ▲ | $13.41M ▼ |
| Q2-2025 | $-9.27M ▲ | $9.3M ▼ | $-10.16M ▼ | $-24.7M ▲ | $-25.11M ▼ | $17.01M ▼ |
| Q1-2025 | $-155.09M ▼ | $26.07M ▲ | $83.55M ▲ | $-109.71M ▼ | $721K ▲ | $18.36M ▲ |
| Q4-2024 | $-84.72M | $8.13M | $-26.27M | $-13.37M | $-32.23M | $-2.77M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Professional Services | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Subscription Services | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ |
Revenue by Geography
| Region | Q1-2022 | Q2-2022 | Q3-2022 | Q4-2022 |
|---|---|---|---|---|
NonUS | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
UNITED STATES | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ | $60.00M ▲ |
Q3 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Definitive Healthcare Corp.'s financial evolution and strategic trajectory over the past five years.
DH combines a strong underlying business model—high gross margins and a subscription-style data platform—with a robust balance sheet marked by high liquidity and very low net debt. Its competitive position benefits from a deep, integrated healthcare dataset, specialized industry focus, and meaningful switching costs for customers. Positive operating and free cash flow, despite reported losses, further underscore the strength of the core cash engine.
The most significant risks are the persistent operating and net losses, which highlight an expense base that is too heavy relative to current revenue. Negative retained earnings and reliance on intangibles signal that past performance has not yet produced durable profitability. Competitive and retention pressures, especially indicated by weakening net dollar retention, raise questions about pricing power and long-term customer stickiness. Regulatory and data-privacy developments in healthcare also remain an ongoing structural risk.
DH’s outlook hinges on its ability to convert a strong strategic and technological position into sustainable economic returns. If management can stabilize and then improve customer retention, grow revenue on top of the existing base, and bring operating costs more in line with scale, the company’s cash generation and balance sheet give it room to improve financial performance over time. Conversely, if growth and retention do not improve, the current pattern of large losses will become more problematic, even with today’s solid liquidity. The path forward is therefore opportunity-rich but execution-sensitive.
About Definitive Healthcare Corp.
https://www.definitivehc.comDefinitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $61.53M ▲ | $73.54M ▲ | $-9.31M ▲ | -15.14% ▲ | $-0.09 ▲ | $-6.6M ▼ |
| Q3-2025 | $60.05M ▼ | $59.66M ▲ | $-14.84M ▼ | -24.71% ▼ | $-0.14 ▼ | $-209K ▼ |
| Q2-2025 | $60.75M ▲ | $50.78M ▼ | $-7.55M ▲ | -12.43% ▲ | $-0.07 ▲ | $8.52M ▲ |
| Q1-2025 | $59.19M ▼ | $228.55M ▲ | $-107.23M ▼ | -181.16% ▼ | $-0.95 ▼ | $-149.73M ▼ |
| Q4-2024 | $62.29M | $147.16M | $-59.08M | -94.84% | $-0.51 | $-73.97M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $180.89M ▼ | $735.49M ▼ | $356.5M ▼ | $378.99M ▲ |
| Q3-2025 | $185.92M ▲ | $755.53M ▼ | $365.86M ▲ | $284.85M ▼ |
| Q2-2025 | $184.2M ▼ | $770.14M ▼ | $358.91M ▼ | $303.62M ▼ |
| Q1-2025 | $200.67M ▼ | $808.66M ▼ | $372.75M ▼ | $322.78M ▼ |
| Q4-2024 | $290.16M | $1.09B | $482.19M | $444.38M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-17.15M ▲ | $2.72M ▼ | $56.35M ▲ | $-3.91M ▲ | $55.31M ▲ | $-1.72M ▼ |
| Q3-2025 | $-17.79M ▼ | $15.69M ▲ | $24.14M ▲ | $-12.47M ▲ | $27.33M ▲ | $13.41M ▼ |
| Q2-2025 | $-9.27M ▲ | $9.3M ▼ | $-10.16M ▼ | $-24.7M ▲ | $-25.11M ▼ | $17.01M ▼ |
| Q1-2025 | $-155.09M ▼ | $26.07M ▲ | $83.55M ▲ | $-109.71M ▼ | $721K ▲ | $18.36M ▲ |
| Q4-2024 | $-84.72M | $8.13M | $-26.27M | $-13.37M | $-32.23M | $-2.77M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Professional Services | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Subscription Services | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ |
Revenue by Geography
| Region | Q1-2022 | Q2-2022 | Q3-2022 | Q4-2022 |
|---|---|---|---|---|
NonUS | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
UNITED STATES | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ | $60.00M ▲ |
Q3 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Definitive Healthcare Corp.'s financial evolution and strategic trajectory over the past five years.
DH combines a strong underlying business model—high gross margins and a subscription-style data platform—with a robust balance sheet marked by high liquidity and very low net debt. Its competitive position benefits from a deep, integrated healthcare dataset, specialized industry focus, and meaningful switching costs for customers. Positive operating and free cash flow, despite reported losses, further underscore the strength of the core cash engine.
The most significant risks are the persistent operating and net losses, which highlight an expense base that is too heavy relative to current revenue. Negative retained earnings and reliance on intangibles signal that past performance has not yet produced durable profitability. Competitive and retention pressures, especially indicated by weakening net dollar retention, raise questions about pricing power and long-term customer stickiness. Regulatory and data-privacy developments in healthcare also remain an ongoing structural risk.
DH’s outlook hinges on its ability to convert a strong strategic and technological position into sustainable economic returns. If management can stabilize and then improve customer retention, grow revenue on top of the existing base, and bring operating costs more in line with scale, the company’s cash generation and balance sheet give it room to improve financial performance over time. Conversely, if growth and retention do not improve, the current pattern of large losses will become more problematic, even with today’s solid liquidity. The path forward is therefore opportunity-rich but execution-sensitive.

CEO
Kevin D. Coop
Compensation Summary
(Year 2024)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 62
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Stephens & Co.
Equal Weight
Canaccord Genuity
Hold
Barclays
Underweight
Stifel
Buy
Goldman Sachs
Neutral
Grade Summary
Showing Top 5 of 5
Price Target
Institutional Ownership
ADVENT INTERNATIONAL CORP/MA
Shares:62.49M
Value:$79.99M
GOLDMAN SACHS GROUP INC
Shares:7.31M
Value:$9.36M
BLACKROCK INC.
Shares:4.42M
Value:$5.66M
Summary
Showing Top 3 of 165

